GDYN (GDYN)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 6/9.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe underlying economics of GDYN present a stark dichotomy between aggressive top-line expansion and deteriorating capital efficiency. While revenue growth is robust at 17.5% year-over-year, supported by healthy gross margins of 34.6%, the company's net margin has compressed to just 2.4%. This compression is exacerbated by negative returns on invested capital (ROIC) of -0.2%, indicating that current operations are destroying value rather than generating it. The DuPont decomposition suggests this poor ROE stems primarily from low asset turnover and insufficient leverage, as the firm fails to convert its growing revenue base into profitable equity returns. Despite a respectable Piotroski F-Score of 6/9 signaling moderate financial strength, the negative ROIC fundamentally undermines the quality of earnings required for sustainable valuation support.
Valuation metrics reflect significant market skepticism regarding the durability of current growth rates in light of weak profitability. The stock trades at an exorbitant forward P/E multiple of 117.5x, which is detached from its ability to generate returns on capital and vastly exceeds typical benchmarks for firms with negative ROIC. A discounted cash flow analysis implies a fair value of $9 per share, suggesting the current market price assumes growth persistence that contradicts the observed erosion in net margins and return metrics. The market appears priced in an idealized scenario where high revenue velocity translates directly into scaled profits, ignoring the immediate drag on bottom-line performance evident in the 2.4% net margin.
The divergence between the moderate Beneish M-Score of -2.55, which often flags low earnings manipulation risk, and the negative ROIC creates a complex risk-reward profile for long-term holders. While the Fama-French alpha data is not provided to assess style exposure, the combination of high valuation multiples with capital-destructive operations introduces significant downside volatility if growth slows even marginally. Investors must weigh whether the 17.5% revenue trajectory can eventually reverse the negative ROIC trend before the current premium multiple contracts sharply toward DCF-implied levels.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 8% | 10% | 12% |
|---|---|---|---|
| 2% | $10 | $9 | $8 |
| 3% | $11 | $9 | $8 |
| 4% | $13 | $10 | $8 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $9 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XSW or VGT, the fund manager is mechanically forced to buy or sell GDYN shares regardless of GDYN's individual fundamentals. We estimate $15M of passive capital is structurally linked to GDYN through 2 tracked ETFs. Passive flows have a limited but growing influence on GDYN's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 2 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in GDYN to visualize passive redemption contagion across ETFs and collateral stocks.
If GDYN (GDYN) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NVIDIA Corp. (NVDA) as the most exposed collateral stock, sharing 1 ETFs with GDYN. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
GDYN Ownership Dynamics
ETFs with Highest GDYN Exposure
Float lock-up computed from 5 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
GDYN Capital Efficiency
How efficiently does GDYN convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
GDYN converts 109% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-06-12 | 8,493 | $6.43 | $54,609.99 |
| 2026-06-09 | 628 | $6.47 | $4,063.16 |
| 2026-06-08 | 270 | $6.55 | $1,768.5 |
| 2026-06-04 | 402 | $7.04 | $2,830.08 |
| 2026-06-03 | 51 | $7.50 | $382.5 |
| 2026-06-02 | 55 | $7.86 | $432.3 |
| 2026-05-29 | 6,473 | $7.37 | $47,706.01 |
| 2026-05-19 | 1,027 | $6.68 | $6,860.36 |
| 2026-05-18 | 1,999 | $6.71 | $13,413.29 |
| 2026-05-13 | 24,507 | $6.66 | $163,216.62 |
| 2026-05-04 | 2,087 | $5.81 | $12,125.47 |
| 2026-04-24 | 474 | $5.57 | $2,640.18 |
| 2026-04-20 | 3,873 | $5.95 | $23,044.35 |
| 2026-04-06 | 46 | $5.77 | $265.42 |
| 2026-03-23 | 443 | $6.02 | $2,666.86 |
| 2026-03-18 | 5,067 | $6.22 | $31,516.74 |
| 2026-03-17 | 5,783 | $6.21 | $35,912.43 |
| 2026-03-03 | 17,701 | $6.83 | $120,897.83 |
| 2026-02-27 | 2,898 | $6.90 | $19,996.2 |
| 2026-02-26 | 8,392 | $6.46 | $54,212.32 |
| 2026-02-25 | 3,795 | $6.45 | $24,477.75 |
| 2026-02-19 | 523 | $7.00 | $3,661 |
| 2026-02-13 | 1,904 | $6.60 | $12,566.4 |
| 2026-02-10 | 8,589 | $7.03 | $60,380.67 |
| 2026-02-04 | 2,316 | $7.16 | $16,582.56 |
| 2026-01-16 | 108 | $9.37 | $1,011.96 |
| 2026-01-05 | 672 | $8.83 | $5,933.76 |
| 2025-12-08 | 537 | $9.49 | $5,096.13 |
| 2025-12-04 | 6,700 | $9.49 | $63,583 |
| 2025-11-26 | 735 | $8.74 | $6,423.9 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare GDYN to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.